Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Screenshots show only minor administrative updates to the page layout and recent update timestamps; no core study content such as eligibility criteria, endpoints, or locations appears added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:05:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    2%
    Check dated 2025-10-06T05:49:29.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0 and added multiple contact phone numbers and emails.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:40.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. Core content and critical data appear unchanged.
    Difference
    0.1%
    Check dated 2025-09-14T19:52:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:54:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new dates relevant to the content. Notably, the drug Sunitinib Malate has been included, while several related terms and older dates have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:09:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.